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X-linked agammaglobulinemia  is characterized in the majority of the cases by the 
absence  of  lymphocytes  bearing  surface  immunoglobulin (sIg+) 1  from  peripheral 
blood, in addition to a  marked decrease of serum Ig levels (1-3). Recently, pre-B cells 
and rare sIg  + B  cells have been demonstrated in the bone marrow of these patients 
(4).  In  contrast,  circulating sIg  +  lymphocytes  are  present  in  most  cases  of severe 
combined  immunodeficiency  (SCID)  and  common  variable  immunodeficiency 
(CVID)  (4-7). 
Epstein-Barr virus  (EBV)-transformed  lymphoblastoid lines have  been obtained 
readily in our laboratory from peripheral blood of normal individuals as well as SCID 
and CVID patients. Repeated attempts to  obtain EBV-transformed cell lines from 
the  blood  of those  with  X-linked agammaglobulinemia have  not  been  successful. 
However, in the present study, multiple EBV-transformed cell lines were established 
from  the  bone  marrow  of  three  patients.  Analysis  of  immunoglobulin synthesis 
indicated  most  of these  lines  differed  markedly  from  those  derived  from  normal 
individuals, with some resembling pre-B cells, and others possible precursor cells of 
the B cell lineage. Preliminary results have been presented previously (8). 
Materials and Methods 
Patients.  Six  cases  of X-linked agammaglobulinemia were  studied.  The  criteria  for  the 
diagnosis included severely depressed Ig levels, lack of sIg  ÷ cells in the circulation, absence of 
specific antibodies with normal in vitro T cell responses  in the mixed lymphocyte reaction and 
to phytohemagglutinin and concanavalin A, a clinical history of early onset of infection, and 
involvement of other male relatives in all cases except patient Ric., from whom no definite 
family history could be elicited. In addition, two sisters with a syndrome indistinguishable  from 
X-linked agammaglobulinemia (9)  were  also  included. Seven patients with CVID and six 
patients with SCID were studied. 
Cell Cultures and Initiation of Cell Lines.  Cell cultures and initiation of cell lines were carried 
out  as  described  previously  (10). Mononuclear cells  isolated  by  Ficoll-Hypaque gradient 
centrifugation were depleted of T  cells by the sheep erythrocyte rosetting method. The non-T 
cells were then used in the initiation  of cell lines. In certain cases, the non-T cells were depleted 
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of monocytes either by the removal of iron-ingesting cells with a magnet or by the removal of 
adherent cells. 
Immunofluorescence and Methods  for Detection of Ig Synthesis.  Detection of sIg  + and intracellular 
Ig and  Ia antigens  by  6 immunofluorescence was carried  out  as  described  (10).  For internal 
labeling, cells  (9 ×  10/ml)  were incubated with  20 #Ci/ml  [aSS]methionine  (700 Ci/mmol, 
New  England  Nuclear  Inc.,  Boston,  Mass.)  in  methionine-free  RPMI-1640  medium  that 
contained 5% dialyzed agammaglobulinemic horse serum (Grand Island Biological Co., Grand 
Island, N. Y.) for 4 h at 37°C in a 5% CO2 humidified atmosphere. After three washes,  the cells 
were lysed in a buffer with  1% Triton X-100 precipitated with either affinity column-purified 
anti-p or anti-light-chain antibodies, and processed for sodium dodecyl sulfate (SDS)-po]yacryl- 
amide gel electrophoresis as previously described (1 I). 
Fc Receptors, C3 Receptors, and Other Methods.  Fc receptors and C3 receptors were detected by 
a  rosette formation method with  either ox erythrocytes coated with  IgG antibodies or IgM 
antibodies plus mouse complement, respectively, as described previously (12). The detection of 
Epstein-Barr viral nuclear antigen (EBNA) was performed as described by Reedman and Klein 
(13). 
Results 
Cell Lines from SCID and CVID Patients.  The non-T fraction of the peripheral blood 
from seven patients with CVID and six patients with SCID was incubated with EBV- 
containing supernates from cell line B95-8. Within 2-4 wk, cell lines were established. 
Morphologically, these cell  lines resembled  those obtained  from normal  individuals. 
They were pleomorphic and grew as clumps in suspension. All these lines were shown 
to  be  EBNA  positive  and  thus  contained  the  EBV  genome.  Immunofluorescence 
analyses  demonstrated  that  all  of these  lines,  with  one exception,  synthesized  both 
membrance and cytoplasmic Ig. The exceptional  line had no detectable cytoplasmic 
or membrane  Ig and  was  from an  SCID patient  in  whom no circulating  sIg  + cells 
were present. 
Cell  Lines from  Patients  with  X-linked Agammaglobulinemia.  Repeated  attempts  to 
derive cell lines with EBV preparations from the peripheral blood of six patients with 
X-linked agammaglobulinemia and two females with a  syndrome clinically indistin- 
guishable  from the X-linked  cases were not successful.  Depletion  of monocytes and 
adherent  cells from the non-T fraction did not help. The ages of these patients were 
8 mo (Josh), 20 yr (Ric), 21  yr (Bry), and 28 yr (Bro). 
Bone marrow aspirates were obtained from four of these patients.  11 cell lines were 
obtained from three of them. No cell lines were obtained from the oldest patient, Bro. 
In general,  it took 4-6 wk to establish  these lines.  Except  for Josh  7, supernates  that 
contained  EBV  from cell  line  B95-8 were used. Josh  7 was established  without  the 
aid  of exogenous  EBV  and  was established  10 wk  after  bone  marrow  cells  were  in 
culture.  10 of the  11  cell lines had growth characteristics  indistinguishable  from the 
common lymphoblastoid lines. Josh 7 was unusual in that the cells were uniform and 
round. This type of unusual round cell line has been reported previously (10). 
Ig Synthesis by  Cell Lines from  Patients  with  X-Linked Agammaglobulinemia.  Either  a 
lack of Ig expression or unusual  Ig patterns  were encountered  in some of these lines 
when immunofluorescence analysis was carried out (Table I). Josh 2 resembled typical 
normal  lines and expressed  both  membrane  IgM and  cytoplasmic IgM with )~ light 
chain.  Both/~ and )~ determinants  were detected  in the supernate. Josh  1 and Josh 5 
had few Ig-containing cells, although none of the cells had sIg. In the case of Josh 4, 
only cytoplasmic #  chain was detected.  The presence of only #  chain was also found 
in the supernate of  Josh 4 by both hemagglutination inhibition and immunoprecipi- FU,  HURLEY,  MeCUNE,  KUNKEL, AND GOOD  1521 
TABLE I 
Percentage of Cells in Different Cell Lines from Patients with X-Linked Agaramaglobulinemia Showing 
Membrane Ig and Cytoplasmic Ig as Detected by Fluorescence with Ig Antisera 
Cell lines 
Membrane lg  Cytoplasmic Ig 
IgM  IgG  IgA  K  ~  IgM  IgG  IgA  x  )k 
%  % 
Josh 
1  0  0  0  0  0  0*  0*  0  0  0* 
2  18  0  0  0  18  33  0  0  0  37 
3  0  0  0  0  0  0  0  0  0  0 
4  0  0  0  0  0  47  0  0  0  0 
5  0  0  0  0  0  1  0  0  2  2 
6  0  0  0  0  0  0  0  0  0  0 
7  0  0  0  0  0  0  0  0  0  0 
Ric 
1  0  0  0  0  0  45  0  0  0:~  0 
2  0  0  0  0  0  40  0  0  0  0§ 
Bry 
1  0  0  0  0  0  0  0  0  0  0 
2  0  0  0  0  0  0  0  0  0  0 
* Indicates occasional cells stained brightly, and could be identified as plasma cells. 
:~ 20% of the cells stained dully and definitely above background staining, although the staining was much 
less intense than that for IgM. 
§ 28% of the cells stained dully as those in Ric I. 
tation of [aSS]methionine-labeled  chain  identified  by SDS gel electrophoresis.  In the 
two lines from patient Ric, large numbers of brightly stained cells were observed with 
anti-/~ antibodies. This contrasted with faint staining of lesser numbers of cells by the 
anti-light  chain  reagents.  This  finding suggested  the  synthesis  of small  amounts  of 
light chain and was confirmed by biosynthetic studies involving [35S]methionine and 
gel  electrophoresis.  Of  five  cell  lines  in  which  no  Ig  expression  was  shown  by 
fluorescence,  three  (Josh  6,  Bry  1,  and  Bry  2)  were  shown  to  make  detectable 
amounts  of  heavy  and  light  chains  by  biosynthetic  studies.  However,  repeated 
experiments with  [~S]methionine  labeling failed to reveal any lg synthesis in either 
Josh 3 or Josh  7. 
The  following represent  typical  findings  in  the  biosynthetic  studies.  Fig.  1 shows 
the  Ig biosynthetic  patterns  of three  cell  lines  from patient Josh.  Anti-/x antibodies 
brought down both bt and light chains from Josh 2. In the case of  Josh 3, no Ig chain 
was  precipitated.  From Josh  4,  only labeled/~  chain  was  detected.  To exclude  the 
possibility that  this chain existed  in combination with unlabeled light chain  formed 
prior  to  the  [~S]methionine  pulse,  anti-light-chain  antibodies  with  both  K and 
specificities were used as the precipitating antibodies. These anti-light-chain antibod- 
ies brought down both # and L chains from Josh 2, but no Ig chains from either Josh 
3 or Josh 4, thus confirming the absence of light chain in Josh 4. 
Fc Receptors,  C3 Receptors,  and Other Studies.  Ox erythrocytes coated  with  isolated 
IgG antibodies  (EAIgG) were used to detect Fc receptors on the surface of cells. Except 
for Josh  7,  15-30%  of cells  formed  EAtgG  rosettes  with  eight  cell  lines  from  two 
individuals  (Table  II).  In  the  case  of Josh  7,  81%  formed  EAIgG  rosettes.  For  C3 
receptors, EAo~ coated with IgM antibodies were incubated with a C5-deficient mouse 1522  PRECURSOR  LYMPHOID  CELL  LINES 
Fie.  1.  Ig synthesis by three cell lines from a patient with X-linked agammaglobulinemia.  Cells 
were labeled with  [3SS]methionine.  Triton X-100 lysates were precipitated with anti-~ antibodies. 
The  immunoprecipitates  were reduced  and alkylated and analyzed  by eleetrophoresis in  7-15~7~ 
gradient SDS-polyacrylamide gel. (a) cell line Josh 2; (b) cell line Josh 4; and (c) cell line Josh 3. 
serum  to generate EACm. 83%  of cells in Josh  7  formed  EACr, rosettes, and  14-56% 
of cells formed EACm rosettes in the remaining cell line. In all  11  cell lines, >95% of 
the cells stained for Ia antigens and were positive for the EBNA;  spontaneous sheep 
E  rosettes were either absent or very rare. 
Discussion 
Six major types of cell lines were derived from the bone marrow of three patients 
with  X-linked agammaglobulinemia.  The  first type  (Josh  7)  was  unique  in  that  its 
cells were  round  and  uniform  in  shape.  Very  high  percentages  of the  cells  formed 
EAIgo and  EACm rosettes. This line showed a  complete absence of Ig expression and 
belongs to a  group of unusual EBV that contained round cell lines reported previously 
(12).  The  second  type  (represented  by Josh  3)  also  completely  lacks  Ig  synthesis, 
However, it cannot be distinguished from the common B  lymphoblastoid lines in cell FU,  HURLEY,  McCUNE,  KUNKEL, AND  GOOD 
TABLE II 
Expression of Fc and (23 Receptors by Cell Lines from Patients with X-Linked 
Agammaglobulinemzh 
Cell lines  Fc receptor (EAto3  C3 receptor (EACh, 
rosette-forming ceils)*  rosette-forming cells)~: 
%  % 
Josh 
1  28  53 
2  19  47 
3  20  14 
4  30  56 
5  15  46 
6  18  50 
7  81  83 
Ric 
1  22  33 
2  18  48 
* Fc receptors on cells were detected by a rosette formation method with ox 
erythrocytes coated with IgG antibodies. 5-60% of the cells in common EBV- 
transformed  cell  lines from  normal  individuals  and  patients with  other 
conditions formed EAt~ rosettes. 
~: C3 receptors were detected by a rosette formation method with ox erythro- 
cytes coated  with IgM antibodies  and mouse complement.  30-50% of the 
cells in common EBV-transformed cell lines from other individuals formed 
EACm rosettes. 
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morphology,  growth  characteristics,  and  percentages  of EAIgG  and  EACm  rosette- 
forming cells. These two cell lines may represent transformation of B  precursor cells 
at a  stage before the expression of Ig. The third type (Josh 4)  shows an  Ig synthetic 
pattern typical ofpre-B cells (14,  15), in that only cytoplasmic ~t chain was made. The 
fourth  type  (Ric  1  and  2)  express  predominantly  cytoplasmic /x  chain  with  some 
cytoplasmic light-chain synthesis. This pattern of Ig synthesis resembles that of Nalm- 
6-M1, a  leukemic cell line representing malignant transformation of B  cells at a  late 
pre-B cell stage (16). The fifth type (Josh  1, Josh 5, Josh 6, Bry  1, and Bry 2) showed 
synthesis of small amounts of both heavy and light chains without  the expression of 
membrane Ig. The sixth type (Josh  2)  expresses both membrane  and cytoplasmic bt 
and L  chains, and resembles the normal lymphoblastoid lines. 
Extensive experience has  accumulated  in  our  laboratory in establishing lympho- 
blastoid lines from both normal individuals and patients with various disorders. Over 
100  cell  lines  from  peripheral  blood  and  15  cell  lines  from  normal  bone  marrow 
aspirates have been analyzed by immunofluorescence, and they were uniformly found 
to synthesize both membrane and cytoplasmic Ig. Thus,  the patterns of Ig synthesis 
by most of the cell lines from X-linked immunodeficient patients were quite unique. 
The  presence  of EBNA  indicates  that  these  cell  lines  contain  EBV  genome.  It 
suggests that receptors for EBV are present on some if not all B cells at developmental 
stages before sIg synthesis. Thus, like the Abelson virus in the mouse, EBV can infect 
B  cells at  various  stages  of development  (15).  This  hypothesis  is  being  tested  by 
transformation of non-T populations depleted of sIg  + cells from normal individuals. 
The  isoiation of cell lines from  patients with  X-linked agammaglobulinemia was 
initially undertaken in an attempt to obtain cells in culture that reflected the in vivo 1524  PRECURSOR  LYMPHOID CELL  LINES 
defect in Ig synthesis. However, it is clear that at least certain of the cell lines described 
above were of the normal precursor type. This is especially evident from the various 
pre-B  cell  lines.  It  is  also  evident  from  the  round  cell  type  now  obtained  from 
individuals with normal Ig synthesis. Our concept at the present time is that the other 
unique  cell lines, those without  any Ig synthesis, and  those with very little Ig, may 
also represent precursor cell types. It became clear in this study that the absence of 
mature B  cells in  these patients  played a  major role in  the  isolation of the unique 
types; ordinarily, the mature B cells would be transformed and overgrow the culture 
system. Thus, it would  appear that  these cases represent a  fertile source of material 
for studying B cell ontogeny. However, the possibility that some of the cell lines reflect 
abnormal Ig synthesis characteristic  of the disease has not  been ruled  out.  It seems 
more likely, as has been proposed before (4), that the disease results from a  failure of 
terminal differentiation of normal precursor cells. 
It has become apparent that these cell lines are of considerable value for the study 
of  precursor  B  cells.  For  example,  it  has  been  demonstrated  that  two  distinct 
translation  products of human/~ chain representing the heavy chain of membrane- 
bound and secreted IgM were in cells of B lymphoblastoid lines as well as in mature 
B  cells  (11).  Results  involving  in  vitro  translation  of extracted  messenger  RNA 
(mRNA) from Josh 4 indicate the presence of two species of/~ chain mRNA and the 
absence of light  chain  mRNA.  Experiments  are  in  progress  to  determine  whether 
these two/~ chains are analogous to those found in the more mature B cells.  If this 
proves to be the case, it suggests that light-chain expression may play an important 
role in determining membrane/~ chain transport to the cell surface. In addition, these 
lines should  prove a  valuable source for the isolation of DNA in order to study the 
nature of the genes coding for Ig during the early period of human B cell development. 
The establishment  of EBV-transformed lymphoblastoid lines of the  normal  type 
from  peripheral  blood  of patients  with  CVID  and  SCID  agrees  with  the  results 
reported by other investigators  (17-19).  The lack of success in obtaining B  lympho- 
blastoid lines from peripheral blood of patients with X-linked agammaglobulinemia 
is  also in  agreement with  a  previous report  that,  only in  rare patients of X-linked 
agammaglobulinemia with  circulating sIg  ÷ cells,  EBV-transformed  lymphoblastoid 
lines  were  established  (18).  Recently,  successful  establishment  of  cell  lines  that 
expressed both sIg and cytoplasmic Ig from peripheral blood of the common type of 
patients was reported (19). Finally, the fact that more ceil lines were established from 
the bone marrow of the youngest patient  (Josh)  in the present  report suggests that 
there may be more precursor B cells and some mature sIg  + B cells in the bone marrow 
of patients with this disorder at an early age. There is a  decline of these precursor B 
cells  as  the  patients  grow  older.  The  mechanism  for  this  decline  is  not  readily 
apparent. However, further documentation of this impression is needed. 
Summary 
A  group of unique  Epstein-Barr  virus-containing cell  lines was derived  from the 
bone marrow of three patients with X-linked agammaglobulinemia. Efforts to obtain 
cell  lines  from the  peripheral  blood  of these  patients  were  uniformly unsuccessful. 
Immunofluorescence  analyses  as  well  as  biosynthetic  studies  with  [35S]methionine 
indicated  unusual  patterns  of Ig synthesis  in  many of these  bone marrow derived 
lines. Seven of the lines were of particular interest in that two produced no Ig of any FU,  HURLEY,  McCUNE,  KUNKEL, AND GOOD  1525 
type; two others showed no Ig by fluorescence but small amounts by [35S]methionine 
labeling; one expressed only cytoplasmic/~ chains without any evidence of light chain 
synthesis,  and  two  produced  primarily  /~  chains  with  only slight  amounts  of light 
chains. One of the lines without membrane or cytoplasmic Ig studied  in detail  grew 
like a  typical lymphoid line and was carried  in intermittent  culture over a  period of 
2 yr without Ig expression. One line grew quite differently and resembled  the round 
cell type described previously, which has been obtained from a variety of sources. The 
cell line with cytoplasmic ~ chains and no light-chain expression had the characteristic 
properties of pre-B cells. Three normal type Ig-producing cell lines also were obtained 
from the patients. 
The  accumulated  evidence  obtained  in  the  present  study  indicates  that  these 
unusual cell lines represent normal precursor cells of the B-cell lineage; these grew out 
in these cases because of the virtual absence of mature B cells that ordinarily overgrow 
the  culture  system.  However,  the  possibility  that  in  certain  instances  they  reflect 
abnormal Ig synthesis characteristic of the disease has not been ruled out. 
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